VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors GBX 14.70 +0.15 (+1.04%) As of 09:47 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock CYBG vs. CCFS, CIHL, IL0A, OCI, JESC, BGSC, SLS, TRG, P2P, and SOIShould you be buying VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? The main competitors of VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), Oakley Capital Investments (OCI), JPMorgan European Smaller Companies Trust (JESC), BMO Global Smaller Companies (BGSC), Standard Life UK Smaller Companies Trust (SLS), The European Smaller Companies Trust (TRG), P2P Global Investments (P2P), and Schroder Oriental Income (SOI). VanEck Bionic Engineering UCITS ETF A Acc vs. Charter Court Financial Services Grp Caribbean Investment Permanent TSB Group Oakley Capital Investments JPMorgan European Smaller Companies Trust BMO Global Smaller Companies Standard Life UK Smaller Companies Trust The European Smaller Companies Trust P2P Global Investments Schroder Oriental Income VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Charter Court Financial Services Grp (LON:CCFS) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, community ranking and valuation. Is CYBG or CCFS a better dividend stock? VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio. Does the MarketBeat Community believe in CYBG or CCFS? VanEck Bionic Engineering UCITS ETF A Acc received 104 more outperform votes than Charter Court Financial Services Grp when rated by MarketBeat users. However, 73.88% of users gave Charter Court Financial Services Grp an outperform vote while only 50.88% of users gave VanEck Bionic Engineering UCITS ETF A Acc an outperform vote. CompanyUnderperformOutperformVanEck Bionic Engineering UCITS ETF A AccOutperform Votes20350.88% Underperform Votes19649.12% Charter Court Financial Services GrpOutperform Votes9973.88% Underperform Votes3526.12% Does the media favor CYBG or CCFS? In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Charter Court Financial Services Grp'saverage media sentiment score. Company Overall Sentiment VanEck Bionic Engineering UCITS ETF A Acc Neutral Charter Court Financial Services Grp Neutral Is CYBG or CCFS more profitable? Company Net Margins Return on Equity Return on Assets VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A Charter Court Financial Services Grp N/A N/A N/A Which has stronger valuation and earnings, CYBG or CCFS? VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVanEck Bionic Engineering UCITS ETF A Acc£1.24B0.17N/A-£7.10-2.07Charter Court Financial Services Grp£221.10M0.00N/A£46.30N/A SummaryVanEck Bionic Engineering UCITS ETF A Acc beats Charter Court Financial Services Grp on 4 of the 7 factors compared between the two stocks. Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYBG vs. The Competition Export to ExcelMetricVanEck Bionic Engineering UCITS ETF A AccBanks IndustryFinance SectorLON ExchangeMarket Cap£210.94M£210.94M£11.11B£2.56BDividend Yield2.25%2.25%5.77%4.97%P/E Ratio-2.07N/A22.10132.50Price / Sales0.1717.0426.31227,865.53Price / Cash0.130.1317.6028.11Price / Book0.040.042.674.54Net IncomeN/AN/A£1.03B£5.84B7 Day PerformanceN/A0.46%0.77%3.31%1 Month PerformanceN/A-0.41%-0.17%9.43%1 Year PerformanceN/A-2.72%538.56%114.47% VanEck Bionic Engineering UCITS ETF A Acc Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYBGVanEck Bionic Engineering UCITS ETF A AccN/AGBX 14.71+1.0%N/AN/A£210.94M£1.24B-2.075,762CCFSCharter Court Financial Services GrpN/AN/AN/AN/A£713.62M£221.10M6.37676Gap UpCIHLCaribbean InvestmentN/AN/AN/AN/A£35.27M£29.20M3.08N/AGap UpHigh Trading VolumeIL0APermanent TSB GroupN/AN/AN/AN/A£12.99M£406M5.532,236News CoverageOCIOakley Capital InvestmentsN/AGBX 452+0.2%N/A-1.9%£797.38M£99.08M9.06N/ANews CoverageJESCJPMorgan European Smaller Companies TrustN/AN/AN/AN/A£795.72M£114.05M7.60N/ABGSCBMO Global Smaller CompaniesN/AN/AN/AN/A£769.56M£303.85M2.77N/ASLSStandard Life UK Smaller Companies TrustN/AN/AN/AN/A£715.41M£222.48M3.3710TRGThe European Smaller Companies TrustN/AN/AN/AN/A£701.52M£340.08M2.13N/AP2PP2P Global InvestmentsN/AN/AN/AN/A£617.42M£119.18M20.91N/ASOISchroder Oriental IncomeN/AGBX 260.32+0.3%N/A+0.2%£605.31M£119.46M5.70180 Related Companies and Tools Related Companies Charter Court Financial Services Grp Competitors Caribbean Investment Competitors Permanent TSB Group Competitors Oakley Capital Investments Competitors JPMorgan European Smaller Companies Trust Competitors BMO Global Smaller Companies Competitors Standard Life UK Smaller Companies Trust Competitors The European Smaller Companies Trust Competitors P2P Global Investments Competitors Schroder Oriental Income Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CYBG) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Bionic Engineering UCITS ETF A Acc Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Bionic Engineering UCITS ETF A Acc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
